CVS Health Corporation
CVS
$61.10
-$2.56-4.02%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 10.88% | 10.26% | 10.15% | 10.42% | 10.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.88% | 10.26% | 10.15% | 10.42% | 10.56% |
| Cost of Revenue | 13.20% | 12.44% | 12.08% | 11.96% | 11.62% |
| Gross Profit | -0.72% | -0.39% | 0.80% | 3.10% | 5.54% |
| SG&A Expenses | 3.50% | 2.39% | 3.09% | 2.49% | 3.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.00% | 11.17% | 10.92% | 10.72% | 10.48% |
| Operating Income | -10.88% | -7.23% | -4.88% | 4.65% | 12.12% |
| Income Before Tax | 91.45% | 172.98% | -61.69% | -45.33% | -43.99% |
| Income Tax Expenses | 85.88% | 207.25% | -54.60% | -33.94% | -40.17% |
| Earnings from Continuing Operations | 93.39% | 162.93% | -63.89% | -48.76% | -45.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -50.00% | -162.50% | -340.00% | -275.00% | -233.33% |
| Net Income | 93.55% | 162.93% | -64.22% | -49.10% | -45.50% |
| EBIT | -10.88% | -7.23% | -4.88% | 4.65% | 12.12% |
| EBITDA | -7.86% | -5.76% | -4.72% | 2.21% | 7.62% |
| EPS Basic | 97.16% | 167.52% | -62.88% | -48.16% | -45.13% |
| Normalized Basic EPS | -10.64% | -5.62% | -3.24% | 6.22% | 12.39% |
| EPS Diluted | 99.39% | 172.04% | -62.89% | -48.33% | -45.53% |
| Normalized Diluted EPS | -10.42% | -5.39% | -2.80% | 6.63% | 12.50% |
| Average Basic Shares Outstanding | -2.08% | -1.88% | -1.46% | -1.00% | -0.47% |
| Average Diluted Shares Outstanding | -2.31% | -2.13% | -1.92% | -1.39% | -0.58% |
| Dividend Per Share | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% |
| Payout Ratio | -0.44% | -0.59% | 2.03% | 1.16% | 1.03% |
